To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial Rosacea
Status:
Completed
Trial end date:
2018-09-28
Target enrollment:
Participant gender:
Summary
To demonstrate the superiority of the efficacy of the test and reference products over that
of the placebo control in the treatment of moderate facial rosacea.